Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Panitumumab in Combination With Cisplatin/Gemcitabine Chemotherapy in Patients With Cholangiocarcinomas - a Randomized Clinical Phase II Study

NCT01320254 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01320254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01320254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Panitumumab in Combination With Cisplatin/Gemcitabine Chemotherapy in Patients With Cholangiocarcinomas - a Randomized Clinical Phase II Study
Lead sponsor
Hannover Medical School
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
September 12, 2016
Enrollment
93 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinomas